The Trump administration has successfully appointed permanent leaders to four critical divisions within the Food and Drug Administration, marking a significant step in establishing its executive team. The announcement includes Heidi Overton's nomination as FDA head, positioning the agency with fresh leadership to address regulatory priorities and public health initiatives. These strategic appointments aim to strengthen FDA operations and streamline decision-making processes across key departments.

Summary auto-generated by AI from the original publisher's content. Editorial standards.